Symposium: "Oncology leadership in Asia"

Dong Young Noh, Jae Kyung Roh, Yeul Hong Kim, Kazuhiro Yoshida, Hideo Baba, Marie Cherry Lynn Samson-Fernando, Sanjeev Misra, Zeba Aziz, Rainy Umbas, Yogendra P. Singh, Tony Shu Kam Mok, Han Kwang Yang, Hideyuki Akaza

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The symposium on "Oncology Leadership in Asia" was held as part of the official program of the 42nd Annual Meeting of the Korean Cancer Association with International Cancer Conference. Given the increasing incidence of cancer in all countries and regions of Asia, regardless of developmental stage, and also in light of the recognized need for Asian countries to enhance collaboration in cancer prevention, research, treatment and follow-up, the symposium was held with the aim of bringing together oncology specialists from eight countries and regions in Asia to present the status in their own national context and discuss the key challenges and requirements in order to establish a greater Asian presence in the area of cancer control and research. The task of bringing together diverse countries and regions is made all the more urgent in that while Asia now accounts for more than half of all new cancer cases globally, clinical guidelines are based predominantly on practices adopted in Western countries, which may not be optimized for unique ethnic, pharmacogenomic and cultural characteristics in Asia. Recognizing the need for Asia to better gather information and data for the compilation of Asia-specific clinical guidelines, the participants discussed the current status in Asia in the national and regional contexts and identified future steps towards integrated and collaborative initiatives in Asia. A key outcome of the symposium was a proposal to combine and integrate the activities of existing pan-Asian societies, including the Asian Pacific Federation of Organizations for Cancer Research and Control (APFOCC) and Asian Clinical Oncology Society (ACOS). Further proposals included the expansion of pan-Asian society membership to include individuals and the essential need to encourage the participation of young researchers in order to ensure self-sustainability of cancer control efforts in the future.

Original languageEnglish
Pages (from-to)283-291
Number of pages9
JournalCancer Research and Treatment
Volume49
Issue number2
DOIs
Publication statusPublished - 2017 Apr 1

Fingerprint

Neoplasms
Research
Guidelines
Cultural Characteristics
Medical Oncology
Pharmacogenetics
Research Personnel
Organizations
Incidence

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Noh, D. Y., Roh, J. K., Kim, Y. H., Yoshida, K., Baba, H., Samson-Fernando, M. C. L., ... Akaza, H. (2017). Symposium: "Oncology leadership in Asia". Cancer Research and Treatment, 49(2), 283-291. https://doi.org/10.4143/crt.2017.090

Symposium : "Oncology leadership in Asia". / Noh, Dong Young; Roh, Jae Kyung; Kim, Yeul Hong; Yoshida, Kazuhiro; Baba, Hideo; Samson-Fernando, Marie Cherry Lynn; Misra, Sanjeev; Aziz, Zeba; Umbas, Rainy; Singh, Yogendra P.; Mok, Tony Shu Kam; Yang, Han Kwang; Akaza, Hideyuki.

In: Cancer Research and Treatment, Vol. 49, No. 2, 01.04.2017, p. 283-291.

Research output: Contribution to journalArticle

Noh, DY, Roh, JK, Kim, YH, Yoshida, K, Baba, H, Samson-Fernando, MCL, Misra, S, Aziz, Z, Umbas, R, Singh, YP, Mok, TSK, Yang, HK & Akaza, H 2017, 'Symposium: "Oncology leadership in Asia"', Cancer Research and Treatment, vol. 49, no. 2, pp. 283-291. https://doi.org/10.4143/crt.2017.090
Noh DY, Roh JK, Kim YH, Yoshida K, Baba H, Samson-Fernando MCL et al. Symposium: "Oncology leadership in Asia". Cancer Research and Treatment. 2017 Apr 1;49(2):283-291. https://doi.org/10.4143/crt.2017.090
Noh, Dong Young ; Roh, Jae Kyung ; Kim, Yeul Hong ; Yoshida, Kazuhiro ; Baba, Hideo ; Samson-Fernando, Marie Cherry Lynn ; Misra, Sanjeev ; Aziz, Zeba ; Umbas, Rainy ; Singh, Yogendra P. ; Mok, Tony Shu Kam ; Yang, Han Kwang ; Akaza, Hideyuki. / Symposium : "Oncology leadership in Asia". In: Cancer Research and Treatment. 2017 ; Vol. 49, No. 2. pp. 283-291.
@article{85c66e1a2d004a1dbd311be42c636470,
title = "Symposium: {"}Oncology leadership in Asia{"}",
abstract = "The symposium on {"}Oncology Leadership in Asia{"} was held as part of the official program of the 42nd Annual Meeting of the Korean Cancer Association with International Cancer Conference. Given the increasing incidence of cancer in all countries and regions of Asia, regardless of developmental stage, and also in light of the recognized need for Asian countries to enhance collaboration in cancer prevention, research, treatment and follow-up, the symposium was held with the aim of bringing together oncology specialists from eight countries and regions in Asia to present the status in their own national context and discuss the key challenges and requirements in order to establish a greater Asian presence in the area of cancer control and research. The task of bringing together diverse countries and regions is made all the more urgent in that while Asia now accounts for more than half of all new cancer cases globally, clinical guidelines are based predominantly on practices adopted in Western countries, which may not be optimized for unique ethnic, pharmacogenomic and cultural characteristics in Asia. Recognizing the need for Asia to better gather information and data for the compilation of Asia-specific clinical guidelines, the participants discussed the current status in Asia in the national and regional contexts and identified future steps towards integrated and collaborative initiatives in Asia. A key outcome of the symposium was a proposal to combine and integrate the activities of existing pan-Asian societies, including the Asian Pacific Federation of Organizations for Cancer Research and Control (APFOCC) and Asian Clinical Oncology Society (ACOS). Further proposals included the expansion of pan-Asian society membership to include individuals and the essential need to encourage the participation of young researchers in order to ensure self-sustainability of cancer control efforts in the future.",
author = "Noh, {Dong Young} and Roh, {Jae Kyung} and Kim, {Yeul Hong} and Kazuhiro Yoshida and Hideo Baba and Samson-Fernando, {Marie Cherry Lynn} and Sanjeev Misra and Zeba Aziz and Rainy Umbas and Singh, {Yogendra P.} and Mok, {Tony Shu Kam} and Yang, {Han Kwang} and Hideyuki Akaza",
year = "2017",
month = "4",
day = "1",
doi = "10.4143/crt.2017.090",
language = "English",
volume = "49",
pages = "283--291",
journal = "Cancer Research and Treatment",
issn = "1598-2998",
publisher = "Korean Society for Thoracic and Cardiovascular Surgery",
number = "2",

}

TY - JOUR

T1 - Symposium

T2 - "Oncology leadership in Asia"

AU - Noh, Dong Young

AU - Roh, Jae Kyung

AU - Kim, Yeul Hong

AU - Yoshida, Kazuhiro

AU - Baba, Hideo

AU - Samson-Fernando, Marie Cherry Lynn

AU - Misra, Sanjeev

AU - Aziz, Zeba

AU - Umbas, Rainy

AU - Singh, Yogendra P.

AU - Mok, Tony Shu Kam

AU - Yang, Han Kwang

AU - Akaza, Hideyuki

PY - 2017/4/1

Y1 - 2017/4/1

N2 - The symposium on "Oncology Leadership in Asia" was held as part of the official program of the 42nd Annual Meeting of the Korean Cancer Association with International Cancer Conference. Given the increasing incidence of cancer in all countries and regions of Asia, regardless of developmental stage, and also in light of the recognized need for Asian countries to enhance collaboration in cancer prevention, research, treatment and follow-up, the symposium was held with the aim of bringing together oncology specialists from eight countries and regions in Asia to present the status in their own national context and discuss the key challenges and requirements in order to establish a greater Asian presence in the area of cancer control and research. The task of bringing together diverse countries and regions is made all the more urgent in that while Asia now accounts for more than half of all new cancer cases globally, clinical guidelines are based predominantly on practices adopted in Western countries, which may not be optimized for unique ethnic, pharmacogenomic and cultural characteristics in Asia. Recognizing the need for Asia to better gather information and data for the compilation of Asia-specific clinical guidelines, the participants discussed the current status in Asia in the national and regional contexts and identified future steps towards integrated and collaborative initiatives in Asia. A key outcome of the symposium was a proposal to combine and integrate the activities of existing pan-Asian societies, including the Asian Pacific Federation of Organizations for Cancer Research and Control (APFOCC) and Asian Clinical Oncology Society (ACOS). Further proposals included the expansion of pan-Asian society membership to include individuals and the essential need to encourage the participation of young researchers in order to ensure self-sustainability of cancer control efforts in the future.

AB - The symposium on "Oncology Leadership in Asia" was held as part of the official program of the 42nd Annual Meeting of the Korean Cancer Association with International Cancer Conference. Given the increasing incidence of cancer in all countries and regions of Asia, regardless of developmental stage, and also in light of the recognized need for Asian countries to enhance collaboration in cancer prevention, research, treatment and follow-up, the symposium was held with the aim of bringing together oncology specialists from eight countries and regions in Asia to present the status in their own national context and discuss the key challenges and requirements in order to establish a greater Asian presence in the area of cancer control and research. The task of bringing together diverse countries and regions is made all the more urgent in that while Asia now accounts for more than half of all new cancer cases globally, clinical guidelines are based predominantly on practices adopted in Western countries, which may not be optimized for unique ethnic, pharmacogenomic and cultural characteristics in Asia. Recognizing the need for Asia to better gather information and data for the compilation of Asia-specific clinical guidelines, the participants discussed the current status in Asia in the national and regional contexts and identified future steps towards integrated and collaborative initiatives in Asia. A key outcome of the symposium was a proposal to combine and integrate the activities of existing pan-Asian societies, including the Asian Pacific Federation of Organizations for Cancer Research and Control (APFOCC) and Asian Clinical Oncology Society (ACOS). Further proposals included the expansion of pan-Asian society membership to include individuals and the essential need to encourage the participation of young researchers in order to ensure self-sustainability of cancer control efforts in the future.

UR - http://www.scopus.com/inward/record.url?scp=85017340930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017340930&partnerID=8YFLogxK

U2 - 10.4143/crt.2017.090

DO - 10.4143/crt.2017.090

M3 - Article

C2 - 28279063

AN - SCOPUS:85017340930

VL - 49

SP - 283

EP - 291

JO - Cancer Research and Treatment

JF - Cancer Research and Treatment

SN - 1598-2998

IS - 2

ER -